SCOPUS 정보 검색 플랫폼

European Neuropsychopharmacology

Volumn 11, Issue SUPPL. 4, 2001, Pages

Quetiapine - Efficacy in different domains

(1) Sharma, Tonmoy a

a NEUROSCIENCE RESEARCH CENTRE (United Kingdom)

Author keywords

Atypical antipsychotic; Clinical efficacy; Cognitive function; Quetiapine; Tolerability

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; QUETIAPINE;

ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034803443 PISSN: 0924977X EISSN: None Source Type: Journal
DOI: 10.1016/S0924-977X(01)00112-2 Document Type: Article

Times cited : (14)

References (33)

1
- 0020578407
- The specificity of Bleulerian and Schneiderian symptoms: A critical reevaluation
- (1983) Psychiatr. Clin. North Am. , vol.6 , pp. 41-54
- Andreasen, N.C.¹ Akiskal, H.S.²

2
- 0030795988
- Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
- The Seroquel Trial 13 Study Group
- (1997) Biol. Psychiatry , vol.42 , pp. 233-246
- Arvanitis, L.A.¹ Miller, B.G.²

3
- 0030944708
- Neurocognitive impairment in schizophrenia and how it affects treatment options
- (1997) Can. J. Psychiatry , vol.42 , pp. 255-264
- Bilder, R.M.¹

4
- 0026704061
- Medication effects: Conceptual and methodological issues in schizophrenia research
- (1992) Clin. Psychol. Rev. , vol.12 , pp. 345-361
- Blanchard, J.J.¹ Neale, J.M.²

5
- 0025635720
- Effects in neuropsychological function in chronic schizophrenic patients
- (1990) Schizophr. Bull. , vol.16 , pp. 477-499
- Cassens, G.¹ Inglis, A.K.² Appelbaum, P.S.³ Gutheil, T.G.⁴

6
- 0027152124
- Cognitive deficits in schizophrenia
- (1993) Psychiatr. Clin. North. Am. , vol.16 , pp. 295-312
- Gold, J.M.¹ Harvey, P.D.²

7
- 0029918481
- What are the functional consequences of neurocognitive deficits in schizophrenia?
- (1996) Am. J. Psychiatry , vol.153 , pp. 321-330
- Green, M.F.¹

8
- 0034670602
- Practice-related improvement in information processing with novel antipsychotic treatment
- (2000) Schizophr. Res. , vol.46 , pp. 139-148
- Harvey, P.D.¹ Moriarty, P.J.² Serper, M.R.³ Schnur, E.⁴ Lieber, D.⁵

9
- 0028022630
- One hundred years of schizophrenia: A meta-analysis of the outcome literature
- (1994) Am. J. Psychiatry , vol.151 , pp. 1409-1416
- Hegarty, J.D.¹ Baldessarini, R.J.² Tohen, M.³ Waternaux, C.⁴ Oepen, G.⁵

10
- 4243412974
- 'Seroquel': Efficacy in improving mood, aggression and hostility of schizophrenia
- (1998) Eur. Psychiatr. , vol.13 , Issue.307 S
- Hellewell, J.S.E.¹ Cantillon, M.² Atkinson, G.A.³

11
- 0003386018
- Seroquel (quetiapine) improves psychotic symptoms associated with Parkinson's Disease
- Washington DC, USA
- (1999) American Psychiatric Association Annual Meeting
- Juncos, J.¹ Yeung, P.² Sweitzer, D.³ Arvanitis, L.⁴ Nemeroff, C.⁵

12
- 0034189369
- Review of quetiapine and its clinical applications in schizophrenia
- (2000) Exp. Opin. Pharmacother. , vol.1 , pp. 783-801
- Kasper, S.¹ Müller-Spahn, F.²

13
- 0033021909
- The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
- (1999) Schizophr. Bull. , vol.25 , pp. 201-221
- Keefe, R.S.E.¹ Silva, S.G.² Perkins, D.O.³ Lieberman, J.A.⁴

14
- 0003737797
- University of Leipzig, Leipzig
- (1899) Psychiatrie: Ein Lehrbuch für Studierende und Aerzte, 5th Edition
- Kraepelin, E.¹

15
- 0033547626
- Functional magenetic resonance imaging in neuropsychiatry
- (1999) Br. Med. J. , vol.319 , pp. 1551-1554
- Longworth, C.¹ Honey, G.² Sharma, T.³

16
- 0023736877
- The effects of neuroleptics on neuropsychological test results of schizophrenics
- (1988) Arch. Clin. Neuropsychol. , vol.3 , pp. 247-249
- Medalia, A.¹ Gold, J.M.² Merriam, A.³

17
- 0030745593
- Is it possible to be schizophrenic yet neuropsychologically normal?
- (1997) Neuropsychology , vol.11 , pp. 437-446
- Palmer, B.W.¹ Heaton, R.K.² Paulsen, J.S.³ Kuck, J.⁴ Braff, D.⁵ Harris, M.J.⁶ Zisook, S.⁷ Jeste, D.V.⁸

18
- 0035036143
- Neuropsychological change in schizophrenia after 6 months of double-blind treatment with quetiapine or haloperidol
- (2001) J. Psychiatry Neurosci. , vol.26 , pp. 137-149
- Purdon, S.¹ Malla, A.² Labelle, A.³ Litt, W.⁴

19
- 0003888182
- American Psychiatric Association, Washington DC, USA
- (1999) Quetiapine and risperidone in outpatients with psychotic disorders: results of the QUEST trial (Poster)
- Reinstein, M.¹ Baria, M.² Ginserg, L.³ Sandler, N.⁴ Mullen, J.⁵

20
- 0034713327
- Neuropsychological functioning in first-episode psychosis - Evidence of specific deficits
- (2000) Schizophr. Res. , vol.43 , pp. 47-55
- Riley, E.M.¹ McGovern, D.² Mockler, D.³ Doku, V.C.K.⁴ Óceallaigh, S.⁵ Fannon, D.G.⁶ Tennakoon, L.⁷ Santamaria, M.⁸ Soni, W.⁹ Morris, R.G.¹⁰ Sharma, T.¹¹

21
- 0003391021
- American College of Neuropsychopharmacology, Acapulco, Mexico
- (1999) Quetiapine in neuroleptic-dependent serious mood disorders (Poster)
- Sajatovic, M.¹ Brescan, D.² Perez, D.³ DiGiovanni, S.⁴ Hattab, H.⁵

22
- 0032500624
- Attentional improvement following quetiapine fumarate treatment in schizophrenia
- (1998) Schizophr. Res. , vol.33 , pp. 151-155
- Sax, K.W.¹ Strakowski, S.M.² Keck, P.E.³

23
- 0025879236
- Neuropsychological function in schizophrenia: Selective impairment in memory and learning
- (1991) Arch. Gen. Psychiatry , vol.48 , pp. 618-624
- Saykin, A.J.¹ Gur, R.C.² Gur, R.E.³ Mozley, P.D.⁴ Mozley, L.H.⁵ Resnick, S.M.⁶ Kester, D.B.⁷ Stafiniak, P.⁸

24
- 0003320413
- American Psychiatric Association, Washington DC, USA
- (1999) Effects of Seroquel (quetiapine) on reducing hostility and psychosis in patients with Alzheimer's disease (Poster)
- Schneider, L.¹ Yeung, P.² Sweitzer, D.³ Arvanitis, L.⁴

25
- 0032894685
- The cognitive effects of conventional and atypical antipsychotics in schizophrenia
- (1999) Br. J. Psychiatry , vol.174 , Issue.SUPPL. 38 , pp. 45-51
- Sharma, T.¹

26
- 0003321162
- Cognitive enhancement as a treatment strategy in schizophrenia
- Sharma, T., Harvey, P. (Eds.). Oxford University Press, Oxford
- (2000) Schizophrenia and Cognition
- Sharma, T.¹ Harvey, P.²

27
- 0031943635
- The cognitive efficacy of atypical antipsychotics in schizophrenia
- (1998) J. Clin. Psychopharmacol. , vol.18
- Sharma, T.¹ Mockler, D.²

28
- 0030920294
- Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo
- Seroquel Study Group
- (1997) Arch. Gen. Psychiatry. , vol.54 , pp. 549-557
- Small, J.G.¹ Hirsch, S.R.² Arvanitis, L.A.³ Miller, B.G.⁴ Link, C.G.⁵

29
- 0033815652
- Long-term use of quetiapine in elderly patients with psychotic disorders
- (2000) Clin. Ther. , vol.22 , pp. 1068-1084
- Tariot, P.¹ Salzman, C.² Yeung, P.³ Pultz, J.⁴ Rak, I.H.⁵

30
- 0016237473
- Why do schizophrenic patients refuse to take their drugs?
- (1974) Arch. Gen. Psychiatry. , vol.31 , pp. 67-72
- Van Putten, T.¹

31
- 0030978437
- The functional significance of symptomatology and cognitive function in schizophrenia
- (1997) Schizophr. Res. , vol.25 , pp. 21-31
- Velligan, D.I.¹ Mahurin, R.K.² Diamond, D.L.³

32
- 0033390894
- Cognitive dysfunction in schizophrenia and its importance to outcome: The place of atypical antipsychotics in treatment
- (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 23 , pp. 25-28
- Velligan, D.I.¹ Miller, A.L.²

33
- 0003329164
- American Psychiatric Association, Washington DC, USA
- (1999) Changes in cognitive functioning with quetiapine fumarate versus haloperidol (Poster)
- Velligan, D.I.¹ Newcomer, J.² Pultz, J.³ Csernansky, J.G.⁴ Hoff, A.L.⁵ Mahurin, R.⁶ Miller, A.L.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.